What You Need to Know About Familial Chylomicronemia Syndrome: Pathophysiology, Diagnosis, Management, and the Patient Perspective

1.00 CME
0 MINS
$0 FEE
SAVE

Provider Statement: This continuing education activity is provided by Vindico Medical Education.

Support Statement: This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.

Endorsed by: The National Lipid Association.

There is no non-commercial support for this activity.

Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.

Target Audience: The intended audience for the activity is cardiologists, lipidologists, endocrinologists, and other health care professionals involved in the treatment of patients with FCS.

Purpose/Learning Objectives: Upon successful completion of this educational activity, participants should be better able to:

  • Examine the molecular basis of FCS and the implications for diagnosis, management, and patient quality-of-life.
  • Review the clinical signs and symptoms of FCS, as well as the available tools that can be used to achieve an accurate and timely diagnosis.
  • Evaluate the use of dietary modifications for the management of FCS based on efficacy and impact on patient quality-of-life.
  • Assess available and emerging interventions for the management of FCS.

Activity Chair:
Michael H. Davidson, MD, FACC, FACP, FNLA
Director of the Lipid Clinic
The University of Chicago, Pritzker School of Medicine
Chicago, IL

Nurse Planners:
Joyce L. Ross MSN, CRNP, FNLA

Barbara A. Niedz, PhD, RN, CPHQ

Medical Writer:
Lobna Eldasher, PharmD

Reviewer (ACCME Recertification review on 03/28/2018):
Ronald A. Codario MD, FACP, FNLA, RPVI, CHCP

Jennifer Frederick PharmD, BCPS

Physician Information (Recertified 03/28/2018):
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material was originally approved for 1 year from the date of original release, May 16, 2017 to May 15, 2018. It has since been recertified for an additional 3 months and will now expire on August 15, 2018.

Pharmacist Information (Expired May 15, 2018):
Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This program is acceptable for 1.0 contact hours of Accreditation Council for Pharmacy Education (ACPE) Continuing Education Credit. The ACPE Universal Program Number is 0482-0000-17-002-H01-P, effective 5/15/2017. This is a knowledge-based activity and there is no fee to attend.

Vindico Medical Education will provide Pharmacist credits claimed information directly to the ACPE through CPE Monitor.

Nurse Information (Expired May 15, 2018):
Vindico Medical Education, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is approved for 1.0 contact hour(s) of continuing education the American Association of Nurse Practitioners.

Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.

How to Participate in this Activity and Obtain CME/CNE/CE Credit:
To participate in this CME/CNE/CE activity, you must read the objectives, answer the pretest, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 out of 4 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.

Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education and the American Nurses Credentialing Center’s Standards for Commercial Support, all CME/CNE/CPE providers are required to disclose to the activity audience the relevant financial relationship of the planners, teachers, and authors involved in the development of CME/CNE/CPE content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME/CNE/CPE activity content over which the individual has control.

Faculty member reports the following relationship(s) which are accurate at the time of original content release (05/16/2017):
Michael H. Davidson, MD, FACC, FACP, FNLA
Consulting Fee:  Amgen, AstraZeneca, Merck, Regeneron, Sanofi
Speakers Bureau:
Amgen, Regeneron, Sanofi

Medical Writer reports the following relationship(s) which are accurate at the time of original content release (05/16/2017):
Lobna Eldasher, PharmD
No relevant financial relationship to disclose.

Reviewers report the following relationships which are accurate at the time of original content release (05/16/2017):
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Jennifer Frederick PharmD, BCPS
No relevant financial relationships to disclose.

Nurse Planners report the following relationships which are accurate at the time of original content release (05/16/2017):
Joyce L. Ross, MSN, CRNP, FNLA

Consulting Fee
: Akcea, Kastle Therapeutics
Speakers Bureau
: AbbVie, Amarin, Amgen, Kaneka America, KOWA, Sanofi/Regeneron

Barbara A. Niedz, PhD, RN, CPHQ
No relevant financial relationship to disclose.

Vindico staff report the following relationship(s) which are accurate at the time of original content release (05/16/2017):
No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2017 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME/CNE/CPE Questions?
Contact us at cme@vindicoCME.com